William Blair & Company’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,500
Closed -$113K 2029
2021
Q3
$113K Sell
13,500
-500
-4% -$3.66K ﹤0.01% 1599
2021
Q2
$97K Sell
14,000
-1,500
-10% -$10.5K ﹤0.01% 1617
2021
Q1
$96K Sell
15,500
-9,000
-37% -$59.6K ﹤0.01% 1596
2020
Q4
$125K Sell
24,500
-3,650
-13% -$15.8K ﹤0.01% 1522
2020
Q3
$124K Sell
28,150
-13,500
-32% -$65.8K ﹤0.01% 1399
2020
Q2
$231K Sell
41,650
-18,500
-31% -$103K ﹤0.01% 1182
2020
Q1
$364K Sell
60,150
-11,050
-16% -$93.1K ﹤0.01% 961
2019
Q4
$651K Sell
71,200
-1,500
-2% -$13.9K ﹤0.01% 905
2019
Q3
$662K Sell
72,700
-9,432
-11% -$80.1K ﹤0.01% 863
2019
Q2
$1.17M Sell
82,132
-11,501
-12% -$131K 0.01% 721
2019
Q1
$1.33M Sell
93,633
-12,600
-12% -$217K 0.01% 658
2018
Q4
$1.69M Sell
106,233
-500
-0.5% -$8.62K 0.01% 561
2018
Q3
$2.01M Sell
106,733
-3,150
-3% -$62.7K 0.01% 556
2018
Q2
$2.11M Sell
109,883
-6,000
-5% -$122K 0.01% 543
2018
Q1
$2.48M Sell
115,883
-507
-0.4% -$10.5K 0.02% 507
2017
Q4
$2.39M Sell
116,390
-11,072
-9% -$205K 0.02% 531
2017
Q3
$2.35M Hold
127,462
0.02% 524
2017
Q2
$3.18M Buy
127,462
+7,490
+6% +$157K 0.02% 454
2017
Q1
$2.55M Buy
+119,972
New +$2.63M 0.02% 487

Other funds holding PMD

William Blair & Company's PMD Position: Q4 2021 in Review

William Blair & Company sold out of Psychemedics Corporation (PMD) in Q4 2021, closing a stake of 13,500 shares — an estimated $113K sold.

William Blair & Company first reported a position in PMD in Q1 2017 and held it in 19 quarters. The position peaked at $3.18M in Q2 2017. 25 funds tracked by Wall St. Rank hold PMD as of Q4 2021.

  • William Blair & Company reported no remaining Psychemedics Corporation position as of Q4 2021 after selling out during the quarter.
  • William Blair & Company sold 13,500 Psychemedics Corporation shares in Q4 2021, an estimated $113K.
  • William Blair & Company first reported a position in Psychemedics Corporation in Q1 2017 and held it in 19 quarters.
  • William Blair & Company's Psychemedics Corporation position peaked at $3.18M in Q2 2017.
  • 25 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2021.

Based on William Blair & Company's 13F filing for Q4 2021, filed 14 Feb 2022.